Source: US News & World Report
“Eli Lilly reached a major milestone Friday, becoming the first healthcare company in the world to hit a $1 trillion market value. The drug company briefly crossed the trillion-dollar mark during morning trading before its stock pulled back slightly. Shares were last trading at around $1,048 each. Eli Lilly is now just the second non-technology company in the U.S. to reach a $1 trillion value, after Warren Buffett’s Berkshire Hathaway. Much of that growth comes from two blockbuster drugs: Mounjaro for diabetes and Zepbound for weight loss. The Indianapolis-based drugmaker’s stock is up more than 36% this year, as demand for its weight loss and diabetes treatments continues to rise, CNBC reported.” (11/24/25)